Alma Surgical to Launch the 2nd Generation FemiLift, the FemiLift Smart

Alma Surgical to Launch the 2nd Generation FemiLift, the FemiLift Smart

Alma Surgical to Launch the 2nd Generation FemiLift, the FemiLift Smart, a New Robotic Probe for
Advanced Precision & Faster Treatment of Feminine Health Concerns

The FemiLift Smart, a New Robotic Probe for Homogeneous & Faster Treatments

Rome, Italy — (April 20th, 2016) – Alma Surgical, a division of Alma Lasers, a global innovator of laser, light-based, radiofrequency and
ultrasound solutions for the aesthetic and surgical markets, announced the launch of a new robotic probe, FemiLift Smart, offering practitioners
the most advanced technology on the market which will provide superior clinical results.
Alma FemiLift is a state-of-the-art minimally-invasive outpatient solution that incorporates CO2 laser technology to treat various feminine health
concerns, including vaginal tightening, stress urinary incontinence, vaginal dryness, recurrent vaginal infection, Genito-Urinary Syndrome of
Menopause (GSM), and post-delivery rehabilitation. The procedure is fast, painless and highly effective, delivering superior results with a proven safety record.
With hundreds of surgical practitioners worldwide who currently use the technology and tens of thousands of patients across the globe who have
undergone the procedure, Alma is proud to announce new & exciting technological advancements:
FemiLift Smart Probe- for homogeneous & fast treatment.
This innovative new robotic probe incorporates “smart technology” allowing practitioners to provide fast and homogeneous treatments. The upgraded
platform and probe enable physicians to quickly adjust treatment settings based on the patient’s specific needs. Treatments are carried
out in a 360 / 120 degree pattern providing optimal coverage and protocols are adjustable for a variety of indications. With the FemiLift Smart
Probe, treatment is carried out according to the indication and the parameters of the treatment.
Prof. Paolo Scollo, President S.I.G.O. Rome, Italy added: “FemiLift Smart, the next generation device, represents a novel approach for outpatient medical
treatments. The FemiLift procedure provides excellent and precise results that are free from side effects and completely asymptomatic.”
Alma FemiLift will be on display at booth #06 at E.S.A.G Rome during April 19th- 20th, 2016.